Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis.
Hisao ImaiYutaka YamadaHiroyuki MinemuraTomohide SugiyamaMie KotakeKyoichi KairaKenya KanazawaYoichi NakamuraTakashi KasaiYoko ShibataTakayuki KaburagiKoichi Minatonull nullPublished in: Thoracic cancer (2018)
Although hematological toxicities (particularly neutropenia) were severe, topotecan showed favorable disease control in both sensitive and refractory patients. Topotecan may thus be a preferred treatment for elderly patients with relapsed SCLC.